☆ 4.5 Letter

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

BONE MARROW TRANSPLANTATION (2015)

Get Full Text
Add to Collection

Journal

BONE MARROW TRANSPLANTATION
Volume 50, Issue 8, Pages 1132-1134

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bmt.2015.110

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.